The impact factors on the cost and length of stay among acute ischemic stroke

Ying Chih Huang, Chaur Jong Hu, Tsong Hai Lee, Jen Tsung Yang, Hsu Huei Weng, Leng Chieh Lin, Shiao Lin Lai

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background: Understanding hospital costs and length of stay (LOS) can optimize the in-hospital management of acute stroke. We investigated cost and LOS in first-ever and recurrent stroke patients in Taiwan. Methods: Data were examined in patients at Chang Gung Memorial Hospital in Chiayi County of Taiwan from April 1, 2005, to March 31, 2007. Predictors of hospital cost and LOS in these patients were studied. Results: The study included 1021 patients with 1084 stroke episodes. Mean age was 68.1 ± 10.8 years (range: 32-93). The average cost was NTD$45,709.30 ± NTD$66,697.40 (US$1408.70 ± US$2084.30; US$1 = NTD$32) and average LOS was 13.9 ± 14.1 days (range: 1-129). After multivariate regression analysis, the significant predictive factors for cost were LOS, smoking, and medication for secondary prevention. The significant predictive factors for LOS were diabetes mellitus, atrial fibrillation, recurrence, and stroke subtype. Conclusions: Age 65 and over, atrial fibrillation, stroke treatment, and subtypes were the significant predictive factors affecting hospital costs and LOS. Compared to other countries, Taiwan spent the least while Canada had the highest expense. The United States had the shortest LOS (6 days) in contrast to Canada with the longest LOS (34-47 days). Regarding mean daily cost of stroke, the United States had the highest cost per day while China spent the least.

Original languageEnglish
JournalJournal of Stroke and Cerebrovascular Diseases
Volume22
Issue number7
DOIs
Publication statusPublished - Oct 2013

Fingerprint

Length of Stay
Stroke
Costs and Cost Analysis
Hospital Costs
Taiwan
Atrial Fibrillation
Canada
Secondary Prevention
China
Diabetes Mellitus
Multivariate Analysis
Smoking
Regression Analysis
Recurrence

Keywords

  • acute
  • Cost
  • ischemic stroke
  • length of stay
  • risk factor
  • subtypes

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery
  • Rehabilitation
  • Cardiology and Cardiovascular Medicine

Cite this

The impact factors on the cost and length of stay among acute ischemic stroke. / Huang, Ying Chih; Hu, Chaur Jong; Lee, Tsong Hai; Yang, Jen Tsung; Weng, Hsu Huei; Lin, Leng Chieh; Lai, Shiao Lin.

In: Journal of Stroke and Cerebrovascular Diseases, Vol. 22, No. 7, 10.2013.

Research output: Contribution to journalArticle

Huang, Ying Chih ; Hu, Chaur Jong ; Lee, Tsong Hai ; Yang, Jen Tsung ; Weng, Hsu Huei ; Lin, Leng Chieh ; Lai, Shiao Lin. / The impact factors on the cost and length of stay among acute ischemic stroke. In: Journal of Stroke and Cerebrovascular Diseases. 2013 ; Vol. 22, No. 7.
@article{99e57112fad548ea9b54eecf1edea25e,
title = "The impact factors on the cost and length of stay among acute ischemic stroke",
abstract = "Background: Understanding hospital costs and length of stay (LOS) can optimize the in-hospital management of acute stroke. We investigated cost and LOS in first-ever and recurrent stroke patients in Taiwan. Methods: Data were examined in patients at Chang Gung Memorial Hospital in Chiayi County of Taiwan from April 1, 2005, to March 31, 2007. Predictors of hospital cost and LOS in these patients were studied. Results: The study included 1021 patients with 1084 stroke episodes. Mean age was 68.1 ± 10.8 years (range: 32-93). The average cost was NTD$45,709.30 ± NTD$66,697.40 (US$1408.70 ± US$2084.30; US$1 = NTD$32) and average LOS was 13.9 ± 14.1 days (range: 1-129). After multivariate regression analysis, the significant predictive factors for cost were LOS, smoking, and medication for secondary prevention. The significant predictive factors for LOS were diabetes mellitus, atrial fibrillation, recurrence, and stroke subtype. Conclusions: Age 65 and over, atrial fibrillation, stroke treatment, and subtypes were the significant predictive factors affecting hospital costs and LOS. Compared to other countries, Taiwan spent the least while Canada had the highest expense. The United States had the shortest LOS (6 days) in contrast to Canada with the longest LOS (34-47 days). Regarding mean daily cost of stroke, the United States had the highest cost per day while China spent the least.",
keywords = "acute, Cost, ischemic stroke, length of stay, risk factor, subtypes",
author = "Huang, {Ying Chih} and Hu, {Chaur Jong} and Lee, {Tsong Hai} and Yang, {Jen Tsung} and Weng, {Hsu Huei} and Lin, {Leng Chieh} and Lai, {Shiao Lin}",
year = "2013",
month = "10",
doi = "10.1016/j.jstrokecerebrovasdis.2012.10.014",
language = "English",
volume = "22",
journal = "Journal of Stroke and Cerebrovascular Diseases",
issn = "1052-3057",
publisher = "W.B. Saunders Ltd",
number = "7",

}

TY - JOUR

T1 - The impact factors on the cost and length of stay among acute ischemic stroke

AU - Huang, Ying Chih

AU - Hu, Chaur Jong

AU - Lee, Tsong Hai

AU - Yang, Jen Tsung

AU - Weng, Hsu Huei

AU - Lin, Leng Chieh

AU - Lai, Shiao Lin

PY - 2013/10

Y1 - 2013/10

N2 - Background: Understanding hospital costs and length of stay (LOS) can optimize the in-hospital management of acute stroke. We investigated cost and LOS in first-ever and recurrent stroke patients in Taiwan. Methods: Data were examined in patients at Chang Gung Memorial Hospital in Chiayi County of Taiwan from April 1, 2005, to March 31, 2007. Predictors of hospital cost and LOS in these patients were studied. Results: The study included 1021 patients with 1084 stroke episodes. Mean age was 68.1 ± 10.8 years (range: 32-93). The average cost was NTD$45,709.30 ± NTD$66,697.40 (US$1408.70 ± US$2084.30; US$1 = NTD$32) and average LOS was 13.9 ± 14.1 days (range: 1-129). After multivariate regression analysis, the significant predictive factors for cost were LOS, smoking, and medication for secondary prevention. The significant predictive factors for LOS were diabetes mellitus, atrial fibrillation, recurrence, and stroke subtype. Conclusions: Age 65 and over, atrial fibrillation, stroke treatment, and subtypes were the significant predictive factors affecting hospital costs and LOS. Compared to other countries, Taiwan spent the least while Canada had the highest expense. The United States had the shortest LOS (6 days) in contrast to Canada with the longest LOS (34-47 days). Regarding mean daily cost of stroke, the United States had the highest cost per day while China spent the least.

AB - Background: Understanding hospital costs and length of stay (LOS) can optimize the in-hospital management of acute stroke. We investigated cost and LOS in first-ever and recurrent stroke patients in Taiwan. Methods: Data were examined in patients at Chang Gung Memorial Hospital in Chiayi County of Taiwan from April 1, 2005, to March 31, 2007. Predictors of hospital cost and LOS in these patients were studied. Results: The study included 1021 patients with 1084 stroke episodes. Mean age was 68.1 ± 10.8 years (range: 32-93). The average cost was NTD$45,709.30 ± NTD$66,697.40 (US$1408.70 ± US$2084.30; US$1 = NTD$32) and average LOS was 13.9 ± 14.1 days (range: 1-129). After multivariate regression analysis, the significant predictive factors for cost were LOS, smoking, and medication for secondary prevention. The significant predictive factors for LOS were diabetes mellitus, atrial fibrillation, recurrence, and stroke subtype. Conclusions: Age 65 and over, atrial fibrillation, stroke treatment, and subtypes were the significant predictive factors affecting hospital costs and LOS. Compared to other countries, Taiwan spent the least while Canada had the highest expense. The United States had the shortest LOS (6 days) in contrast to Canada with the longest LOS (34-47 days). Regarding mean daily cost of stroke, the United States had the highest cost per day while China spent the least.

KW - acute

KW - Cost

KW - ischemic stroke

KW - length of stay

KW - risk factor

KW - subtypes

UR - http://www.scopus.com/inward/record.url?scp=84885975400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885975400&partnerID=8YFLogxK

U2 - 10.1016/j.jstrokecerebrovasdis.2012.10.014

DO - 10.1016/j.jstrokecerebrovasdis.2012.10.014

M3 - Article

C2 - 23253537

AN - SCOPUS:84885975400

VL - 22

JO - Journal of Stroke and Cerebrovascular Diseases

JF - Journal of Stroke and Cerebrovascular Diseases

SN - 1052-3057

IS - 7

ER -